Aikido Pharma Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Aikido Pharma Inc in the second quarter 2026?
Aikido Pharma Inc recorded a cumulative net loss of $-68 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -81.44%.

Within the Investment Services industry 76 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 3127 to 3193.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	-75.29 %	-25.58 %	74.07 %	449.55 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-68	-45	-20	112	-18
Return On Equity (TTM)	-81.44 %	-45.34 %	-19.94 %	117.87 %	-34.37 %
DOMH's Total Ranking	# 3193	# 3127	# 51	# 2392	#
Equity (TTM) in Millions	22	32	69	210	89
Seq. Equity Change	-30.68 %	-54.48 %	-67.01 %	137.36 %	108.82 %
Seq. Net Income Change	-	-	-	613.94 %	-

Back to DOMH Management Effectiveness >> DOMH's 5 Years Annual ROE >> Compare DOMH ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 77
Sector	# 861
Overall	# 3193

Return On Equity Statistics
High	Average	Low
855.7 %	-11.75 %	-657.44 %
(Mar 31 2017)		(Mar 31 2016)

DOMH Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	69	40	53	74	102
Y / Y Equity Change	74.07 %	-24.7 %	-28.26 %	-27.39 %	243.02 %
Net Income in Millions	-20	-15	-23	-18	-7
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-29.51 %	-36.89 %	-43.24 %	-24.4 %	-7.06 %

Back to DOMH Management Effectiveness >> DOMH's 5 Years Annual ROE >> Compare DOMH ROE to its Competitors

More Return On Equity Ratios
Investment Services Industry Roe Trends and Statistics
Financial Sector Return On Equity Statistics
DOMH's' Return on Equity at Yahoo Finance
DOMH's Roe Ratio versus Investment Services Industry, Financial Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for DOMH's Competitors
Subscribers only: Roe for Aikido Pharma Inc's Suppliers
Subscribers only: Return On Equity for DOMH's Customers

Companies with similar Return On Equity at Jun 30 2026, within Financial Sector

ROE

Date modified: 2026-09-05T00:04:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.